UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Birtamimab: a new amyloidosis treatment?

Blood, 2023-10, Vol.142 (14), p.1178

Huart, Antoine

2023

Link zum Volltext

Verfügbarkeit prüfen

The HNF1B score is a simple tool to select patients for HNF1B gene analysis

Kidney international, 2014-11, Vol.86 (5), p.1007-1015

2014

Link zum Volltext

Verfügbarkeit prüfen

Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality

Arthritis research & therapy, 2021-12, Vol.23 (1), p.295-295, Article 295

2021

Link zum Volltext

Verfügbarkeit prüfen

Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality

Amyloid, 2019-07, Vol.26 (3), p.128-138

2019

Link zum Volltext

Verfügbarkeit prüfen

Management of a Young Patient With High-risk Multiple Myeloma Complicated by Acquired von Willebrand Syndrome: A Diagnostic and Therapeutic Emergency

Plasmatology, 2024-01, Vol.18

2024

Link zum Volltext

Verfügbarkeit prüfen

New Oral Anticoagulants vs. Vitamin K Antagonists Among Patients With Cardiac Amyloidosis: Prognostic Impact

Frontiers in cardiovascular medicine, 2021-11, Vol.8, p.742428-742428

2021

Link zum Volltext

Verfügbarkeit prüfen

Cryofibrinogenemia: A Marker of Severity of Cryoglobulinemic Vasculitis

The American journal of medicine, 2015-08, Vol.128 (8), p.916-921

2015

Link zum Volltext

Verfügbarkeit prüfen

Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis–Induced Thrombotic Microangiopathies

Kidney international reports, 2021-04, Vol.6 (4), p.1015-1021

2021

Link zum Volltext

Verfügbarkeit prüfen

Gateway and journey of patients with cardiac amyloidosis

ESC Heart Failure, 2020-10, Vol.7 (5), p.2418-2430

2020

Link zum Volltext

Verfügbarkeit prüfen

Pattern of myocardial 99mTc-HMDP uptake and impact on myocardial function in patients with transthyretin cardiac amyloidosis

Journal of nuclear cardiology, 2020-02, Vol.27 (1), p.96-105

2020

Link zum Volltext

Verfügbarkeit prüfen

Spectrum of Kidney Disorders Associated with T-Cell Immunoclones

Journal of clinical medicine, 2022-01, Vol.11 (3), p.604

2022

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of Older Patients (≥60 years) with New-Onset Idiopathic Nephrotic Syndrome Receiving Immunosuppressive Regimen: A Multicentre Study of 116 Patients

Journal of clinical medicine, 2019-03, Vol.8 (3), p.298

2019

Link zum Volltext

Verfügbarkeit prüfen

A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis

Blood, 2020-04, Vol.135 (18), p.1531-1540

2020

Link zum Volltext

Verfügbarkeit prüfen

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

The New England journal of medicine, 2021-07, Vol.385 (1), p.46-58

2021

Link zum Volltext

Verfügbarkeit prüfen

Towards etiological treatments in cardiomyopathies

La Presse médicale (1983), 2024-03, Vol.53 (1), p.104223-104223, Article 104223

2024

Link zum Volltext

Verfügbarkeit prüfen

A Phase 2 Single-Arm Study to Evaluate the Efficacy of Isatuximab, Pomalidomide and Low-Dose Dexamethasone, in Patients with AL Amyloidosis Not in VGPR or Better after Any Previous Therapy (IsAMYP)

Blood, 2022-11, Vol.140 (Supplement 1), p.12618-12620

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Daratumumab Monotherapy in Newly Diagnosed Patients with Stage 3B Light Chain Amyloidosis: A Phase 2 Study By the European Myeloma Network

Blood, 2022-11, Vol.140 (Supplement 1), p.1841-1843

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Daratumumab Monotherapy in Newly Diagnosed Patients with Stage 3B Light Chain Amyloidosis: A Phase 2 Study By the European Myeloma Network

Blood, 2021-11, Vol.138 (Supplement 1), p.2730-2730

2021

Link zum Volltext

Verfügbarkeit prüfen

Hepatocyte Nuclear Factor-1 β Controls Mitochondrial Respiration in Renal Tubular Cells

Journal of the American Society of Nephrology, 2017-11, Vol.28 (11), p.3205-3217

2017

Link zum Volltext

Verfügbarkeit prüfen

Plasma exchange and thrombotic microangiopathies: From pathophysiology to clinical practice

Transfusion and apheresis science, 2020-12, Vol.59 (6), p.102990-102990, Article 102990

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Birtamimab: a new amyloidosis treatment?

The HNF1B score is a simple tool to select patients for HNF1B gene analysis

Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality

Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality

Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey

Management of a Young Patient With High-risk Multiple Myeloma Complicated by Acquired von Willebrand Syndrome: A Diagnostic and Therapeutic Emergency

New Oral Anticoagulants vs. Vitamin K Antagonists Among Patients With Cardiac Amyloidosis: Prognostic Impact

Cryofibrinogenemia: A Marker of Severity of Cryoglobulinemic Vasculitis

Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis–Induced Thrombotic Microangiopathies

Gateway and journey of patients with cardiac amyloidosis

Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: Data from the French Vasculitis Study Group

Pattern of myocardial 99mTc-HMDP uptake and impact on myocardial function in patients with transthyretin cardiac amyloidosis

Spectrum of Kidney Disorders Associated with T-Cell Immunoclones

Outcomes of Older Patients (≥60 years) with New-Onset Idiopathic Nephrotic Syndrome Receiving Immunosuppressive Regimen: A Multicentre Study of 116 Patients

Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Trial

A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

Towards etiological treatments in cardiomyopathies

A Phase 2 Single-Arm Study to Evaluate the Efficacy of Isatuximab, Pomalidomide and Low-Dose Dexamethasone, in Patients with AL Amyloidosis Not in VGPR or Better after Any Previous Therapy (IsAMYP)

Efficacy and Safety of Daratumumab Monotherapy in Newly Diagnosed Patients with Stage 3B Light Chain Amyloidosis: A Phase 2 Study By the European Myeloma Network

Efficacy and Safety of Daratumumab Monotherapy in Newly Diagnosed Patients with Stage 3B Light Chain Amyloidosis: A Phase 2 Study By the European Myeloma Network

Hepatocyte Nuclear Factor-1 β Controls Mitochondrial Respiration in Renal Tubular Cells

Plasma exchange and thrombotic microangiopathies: From pathophysiology to clinical practice

Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case series

Suchergebnisse filtern